Bayer AG Correlations
| BAYZF Stock | USD 20.81 0.35 1.71% |
The current 90-days correlation between Bayer AG and Sanofi ADR is 0.21 (i.e., Modest diversification). The correlation of Bayer AG is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Bayer AG Correlation With Market
Good diversification
The correlation between Bayer AG and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bayer AG and DJI in the same portfolio, assuming nothing else is changed.
Bayer |
The ability to find closely correlated positions to Bayer AG could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bayer AG when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bayer AG - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bayer AG to buy it.
Moving together with Bayer Pink Sheet
| 0.82 | LLY | Eli Lilly Sell-off Trend | PairCorr |
| 0.75 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.86 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.69 | RHHBY | Roche Holding | PairCorr |
| 0.72 | RHHVF | Roche Holding AG | PairCorr |
| 0.79 | AZNCF | AstraZeneca PLC | PairCorr |
| 0.85 | NVS | Novartis AG ADR | PairCorr |
| 0.81 | AZN | AstraZeneca PLC ADR | PairCorr |
| 0.73 | NVSEF | Novartis AG | PairCorr |
| 0.82 | AAGH | America Great Health | PairCorr |
| 0.62 | NNAX | New Momentum | PairCorr |
Moving against Bayer Pink Sheet
| 0.82 | DECK | Deckers Outdoor | PairCorr |
| 0.73 | KSCP | Knightscope | PairCorr |
| 0.52 | STI | Solidion Technology Symbol Change | PairCorr |
| 0.95 | SCHW | Charles Schwab Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.92 | GM | General Motors Aggressive Push | PairCorr |
| 0.88 | MRVL | Marvell Technology Earnings Call This Week | PairCorr |
| 0.88 | ZM | Zoom Video Communications Earnings Call Today | PairCorr |
| 0.88 | ALAB | Astera Labs, Common Tech Boost | PairCorr |
| 0.86 | GVA | Granite Construction | PairCorr |
| 0.86 | CRWD | Crowdstrike Holdings Earnings Call Tomorrow | PairCorr |
| 0.85 | ADSK | Autodesk | PairCorr |
| 0.82 | LLYVK | Liberty Media | PairCorr |
| 0.82 | DXYZ | Destiny Tech100 | PairCorr |
| 0.77 | NVDA | NVIDIA | PairCorr |
| 0.74 | SNOW | Snowflake Trending | PairCorr |
| 0.73 | STLD | Steel Dynamics Fiscal Year End 28th of January 2025 | PairCorr |
| 0.72 | RCAT | Red Cat Holdings Trending | PairCorr |
| 0.7 | PYPL | PayPal Holdings | PairCorr |
| 0.53 | CSTXF | CryptoStar Corp | PairCorr |
| 0.46 | BRK-B | Berkshire Hathaway | PairCorr |
| 0.38 | APLD | Applied Blockchain Trending | PairCorr |
Related Correlations Analysis
| -0.89 | 0.85 | -0.74 | 0.9 | SNY | ||
| -0.89 | -0.88 | 0.84 | -0.88 | BMY | ||
| 0.85 | -0.88 | -0.89 | 0.96 | AZN | ||
| -0.74 | 0.84 | -0.89 | -0.8 | GILD | ||
| 0.9 | -0.88 | 0.96 | -0.8 | NVS | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Bayer Pink Sheet performing well and Bayer AG Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bayer AG's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SNY | 0.90 | (0.22) | 0.00 | (2.27) | 0.00 | 1.74 | 7.81 | |||
| BMY | 1.31 | 0.33 | 0.15 | 3.11 | 1.18 | 2.23 | 14.39 | |||
| AZN | 1.05 | (0.40) | 0.00 | 28.98 | 0.00 | 1.28 | 8.50 | |||
| GILD | 0.91 | 0.22 | 0.11 | 0.57 | 1.00 | 2.17 | 10.80 | |||
| NVS | 0.69 | (0.22) | 0.00 | (0.88) | 0.00 | 1.12 | 6.05 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bayer AG without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Bayer AG Corporate Management
| Sarena Lin | Labor Officer | Profile | |
| Oliver Maier | Head Relations | Profile | |
| Gabriel Harnier | Patents Law | Profile | |
| Heiko Schipper | Member of the Management Board, Head of the Consumer Health Division | Profile | |
| Rodrigo Santos | Member Division | Profile | |
| Michael Preuss | Gov Communications | Profile | |
| Stefan Oelrich | Member of the Management Board, Head of the Pharmaceuticals Division | Profile |